FeesSafety
Pluang+

XRP shows signs of a major price move as Bollinger Bands tighten to August lows.

Technical Signals
03 Nov 2026, 12:29 WIB
Finbold
View Source
Bullish
XRP shows signs of a major price move as Bollinger Bands tighten to August lows.

XRP's Bollinger Bands on the four-hour chart have narrowed to their tightest since August, signaling a potential major price move after weeks of low volatility. Historically, similar compression led to a 71% rally in three days, though the direction of the next breakout remains uncertain. Key price levels to watch are $1.27 for bullish confirmation and $1.23 for bearish pressure. Meanwhile, XRP network activity is growing, with nearly 8,000 new wallets created on November 1, suggesting rising interest despite recent price weakness. XRP currently trades around $1.25, below key moving averages, indicating cautious momentum ahead.

XRP price action is the subject, with Pluang market data providing context as of Nov 03, 2026 16:41 WIB. Among 50 major cryptocurrencies priced on Pluang, 7 rose and 42 fell today. Notable movers include BAT at Rp2.275 with a 1-day change of -5.08% and a Pluang order activity skewed 95% Buy, MANA at Rp1.285 down 4.32% with 98% Sell orders, and SAND at Rp798 down 4.11% with a near-even buy-sell split. The most notable figure is BAT's 95% buy-side order activity.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
1 hour ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
1 hour ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
1 hour ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
2 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App